Abstract
Hybrid liver support systems, which combine living cells of the liver in an extracorporeal circuit, have entered the first clinical trials in patients with acute liver failure. The goal of the different developments is to provide within a few hours a biological support of the patient’s failing liver. Different technical solutions can be found to provide a sufficient functional mass of liver cells to the patient. Within this article, the biotechnical and clinical backgrounds of these developments are discussed, initial clinical results are summarized and an evaluation of this method as experimental treatment is given.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 21 July 1999 Accepted: 26 July 1999
Rights and permissions
About this article
Cite this article
Busse, B., Smith, M. & Gerlach, J. Treatment of acute liver failure: hybrid liver support . Langenbeck's Arch Surg 384, 588–599 (1999). https://doi.org/10.1007/s004230050247
Issue Date:
DOI: https://doi.org/10.1007/s004230050247